Zhao Shuai, Chen Fan, Wang Dunwei, Wang Hongdan, Han Wei, Zhang Yuan
Department of Anesthesiology.
Department of Neurosurgery, First Hospital of Jilin University, Changchun, China.
Medicine (Baltimore). 2019 Jan;98(3):e14209. doi: 10.1097/MD.0000000000014209.
To investigate the effect of smoking cessation before surgery on postoperative pain and analgesic consumption after thoracoscopic radical resection of lung cancer in elderly patients with high nicotine dependence.
A total of 107 male patients, ages 60 to 70 years, undergoing elective thoracoscopic radical lung cancer surgery from July 2017 to July 2018 were enrolled into 3 groups: group A (highly nicotine-dependent and discontinued smoking <3 weeks before surgery, n = 36), group B (highly nicotine-dependent and discontinued smoking >3 weeks before surgery, n = 38), and group C (nonsmokers, n = 33). Postoperative sufentanil consumption, visual analog scale (VAS) pain scores at rest and during cough, rescue analgesia, opioid-related adverse events, and patient satisfaction were assessed from 0 to 48 h postoperatively.
Patient characteristics were comparable among the 3 groups. Sufentanil consumption and VAS pain scores from postoperative 0 to 48 h were significantly higher in groups A and B than in group C. In addition, group B had lower sufentanil consumption and pain scores than group A. No differences in the need for rescue analgesia, patient satisfaction, or occurrence of postoperative adverse events, including nausea, vomiting, respiratory depression, and oversedation, were observed among the 3 groups.
Compared with nonsmokers, highly nicotine-dependent male patients who were deprived of cigarettes experienced more severe pain and required treatment with more sufentanil after thoracoscopic radical lung cancer surgery. Moreover, preoperative smoking cessation at least 3 weeks before surgery led to better postoperative pain outcomes than smoking cessation within 3 weeks of surgery.
探讨术前戒烟对高尼古丁依赖老年肺癌患者胸腔镜根治性切除术后疼痛及镇痛药物用量的影响。
选取2017年7月至2018年7月期间接受择期胸腔镜根治性肺癌手术的107例60至70岁男性患者,分为3组:A组(高尼古丁依赖且术前戒烟<3周,n = 36),B组(高尼古丁依赖且术前戒烟>3周,n = 38),C组(非吸烟者,n = 33)。术后0至48小时评估舒芬太尼用量、静息及咳嗽时视觉模拟评分(VAS)疼痛评分、补救镇痛、阿片类药物相关不良事件及患者满意度。
3组患者的特征具有可比性。术后0至48小时,A组和B组的舒芬太尼用量和VAS疼痛评分显著高于C组。此外,B组的舒芬太尼用量和疼痛评分低于A组。3组在补救镇痛需求、患者满意度或术后不良事件(包括恶心、呕吐、呼吸抑制和过度镇静)的发生率方面未观察到差异。
与非吸烟者相比,高尼古丁依赖的男性患者在胸腔镜根治性肺癌手术后经历了更严重的疼痛,需要更多的舒芬太尼治疗。此外,术前至少3周戒烟比术前3周内戒烟术后疼痛结局更好。